Volpara Solutions Announces Expansion of its Medical Advisory Board
Wellington, NZ, October 29, 2019: Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Advisory Board.
Volpara Signs Distribution Agreement to Sell Transpara™, Screenpoint Medical’s AI Solution for Breast Cancer Detection
Wellington, NZ, July 23, 2019 – Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products to breast imaging clinics...
Swedish Health Services Installs VolparaEnterprise Software to Enhance Mammography Image Quality
Breast Imaging Analytics Software Helps Breast Care Team Deliver Personalized Health with High-Quality Images
Volpara Health Technologies to Acquire MRS Systems, Inc.
Companies Committed to Deliver Technologies Enabling Personalized Breast Care
Journal of Breast Imaging Study Validates VolparaDensity in Tyrer-Cuzick Breast Cancer Risk Model
Wellington, NZ, May 20, 2019 – Research has demonstrated that the use of Volpara Solutions’ Volpara®Density™ software in combination with the Tyrer-Cuzick Breast Cancer Risk Evaluation Tool improves breast cancer...
Volpara Secures Medical Device Single Audit Program (MDSAP) 690110 Certification
MDSAP Certification Satisfies ISO and Regulatory Compliance Requirements for Japan, Australia, Canada, and the United States
Volpara Celebrates 10 Years of Striving to Save Families from Breast Cancer
Volpara Solutions Expands Relationship with GE Healthcare
GE Healthcare is now a global distributor of Volpara®Density™ software
Volpara Solutions Showcases New Research and a New Version of VolparaLive! at ECR
Volpara Solutions’ Quantitative Breast Imaging Tools Support 11 Breast Screening Studies Presented at ECRVIENNA, February 26, 2019 – Volpara Solutions Ltd will launch a new version of the Volpara®Live!™ system...
Volpara Solutions Launches Next-Generation VolparaDensity Software to Support Hologic’s Curved Paddles
Recent FDA Clearance Enhances Breast Density Assessment Performance and Expands the Types of Information Provided to Clinicians
